Human type 2 myeloid dendritic cells produce interferon-λ and amplify interferon-α in response to hepatitis C virus infection

Gastroenterology

Volumn 144, Issue 2, 2013, Pages

  Zhang, Shuye ^a   Kodys, Karen ^a   Li, Kui ^b   Szabo, Gyongyi ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

IL 28B SNP; NK cells; NKT cells; Viral immune regulation

Indexed keywords

ALPHA INTERFERON; DOUBLE STRANDED RNA; GAMMA INTERFERON; INTERFERON; INTERFERON LAMBDA; INTERLEUKIN 28; INTERLEUKIN 28A; INTERLEUKIN 29; PATTERN RECOGNITION RECEPTOR; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG; VIRUS RNA; ANTIVIRUS AGENT; HEPATITIS C ANTIBODY; IL28A PROTEIN, HUMAN; IL29 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE;

ARTICLE; CYTOKINE PRODUCTION; HEPATITIS C; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MYELOID DENDRITIC CELL; NATURAL KILLER T CELL; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; BIOSYNTHESIS; BONE MARROW CELL; CELL CULTURE; CELLULAR IMMUNITY; COMPARATIVE STUDY; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS C VIRUS; IMMUNOLOGY; METABOLISM; REAL TIME POLYMERASE CHAIN REACTION; VIROLOGY;

ANTIVIRAL AGENTS; CELLS, CULTURED; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPACIVIRUS; HEPATITIS C ANTIBODIES; HEPATITIS C, CHRONIC; HUMANS; IMMUNITY, CELLULAR; INTERFERON-ALPHA; INTERFERON-GAMMA; INTERLEUKINS; MYELOID CELLS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, VIRAL;

EID: 84881517083     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2012.10.034     Document Type: Article

References (34)

1. Sarasin-Filipowicz M, Oakeley EJ, Duong FH, et al. Interferon signaling and treatment outcome in chronic hepatitis C. Proc Natl Acad Sci U S A 2008;105:7034-7039.
2. Kelly C, Klenerman P, Barnes E. Interferon lambdas: the next cytokine storm. Gut 2011;60:1284-1293.
3. Pang KR, Wu JJ, Huang DB, et al. Biological and clinical basis for molecular studies of interferons. Methods Mol Med 2005; 116:1-23.
4. Rehermann B. Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence. J Clin Invest 2009;119:1745-1754.
5. Ge D, Fellay J, Thompson AJ, et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 2009;461:399-401.
6. Tanaka Y, Nishida N, Sugiyama M, et al. Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet 2009;41:1105-1109.
7. Suppiah V, Moldovan M, Ahlenstiel G, et al. IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat Genet 2009;41:1100-1104.
8. Thomas DL, Thio CL, Martin MP, et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 2009; 461:798-801.
9. Muir AJ, Shiffman ML, Zaman A, et al. Phase 1b study of pegylated interferon lambda 1 with or without ribavirin in patients with chronic genotype 1 hepatitis C virus infection. Hepatology 2010; 52:822-832.
10. Marukian S, Andrus L, Sheahan TP, et al. Hepatitis C virus induces interferon-lambda and interferon-stimulated genes in primary liver cultures. Hepatology 2011;54:1913-1923.
11. Li K, Li NL, Wei D, et al. Activation of chemokine and inflammatory cytokine response in HCV-infected hepatocytes depends on TLR3 sensing of HCV dsRNA intermediates. Hepatology 2011;55:666-675.
12. Lemon SM. Induction and evasion of innate antiviral responses by hepatitis C virus. J Biol Chem 2010;285:22741-22747.
13. Ziegler-Heitbrock L, Ancuta P, Crowe S, et al. Nomenclature of monocytes and dendritic cells in blood. Blood 2010;116:e74-e80.
14. Piccioli D, Tavarini S, Borgogni E, et al. Functional specialization of human circulating CD16 and CD1c myeloid dendritic-cell subsets. Blood 2007;109:5371-5379.
15. Crozat K, Guiton R, Contreras V, et al. The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8alpha+ dendritic cells. J Exp Med 2010;207: 1283-1292.
16. Jongbloed SL, Kassianos AJ, McDonald KJ, et al. Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens. J Exp Med 2010;207:1247-1260.
17. Poulin LF, Salio M, Griessinger E, et al. Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells. J Exp Med 2010;207:1261-1271.
18. Reizis B, Bunin A, Ghosh HS, et al. Plasmacytoid dendritic cells: recent progress and open questions. Annu Rev Immunol 2011; 29:163-183.
19. Marukian S, Jones CT, Andrus L, et al. Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cells. Hepatology 2008;48:1843-1850.
20. Shiina M, Rehermann B. Cell culture-produced hepatitis C virus impairs plasmacytoid dendritic cell function. Hepatology 2008;47: 385-395.
21. Gondois-Rey F, Dental C, Halfon P, et al. Hepatitis C virus is a weak inducer of interferon alpha in plasmacytoid dendritic cells in comparison with influenza and human herpesvirus type-1. PLoS One 2009;4:e4319.
22. Takahashi K, Asabe S, Wieland S, et al. Plasmacytoid dendritic cells sense hepatitis C virus-infected cells, produce interferon, and inhibit infection. Proc Natl Acad Sci U S A 2010;107:7431-7436.
23. Lauterbach H, Bathke B, Gilles S, et al. Mouse CD8alpha+ DCs and human BDCA3+ DCs are major producers of IFN-lambda in response to poly IC. J Exp Med 2010;207:2703-2717.
24. Lepelley A, Louis S, Sourisseau M, et al. Innate sensing of HIVinfected cells. PLoS Pathog 2011;7:e1001284.
25. Lui G, Manches O, Angel J, et al. Plasmacytoid dendritic cells capture and cross-present viral antigens from influenza-virus exposed cells. PLoS One 2009;4:e7111.
26. Iversen MB, Paludan SR. Mechanisms of type III interferon expression. J Interferon Cytokine Res 2010;30:573-578.
27. Takeuchi O, Akira S. Innate immunity to virus infection. Immunol Rev 2009;227:75-86.
28. Yamazaki C, Miyamoto R, Hoshino K, et al. Conservation of a chemokine system, XCR1 and its ligand, XCL1, between human and mice. Biochem Biophys Res Commun 2010;397:756-761.
29. Sommereyns C, Paul S, Staeheli P, et al. IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo. PLoS Pathog 2008;4:e1000017.
30. Witte K, Gruetz G, Volk HD, et al. Despite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines. Genes Immun 2009;10:702-714.
31. Dolganiuc A, Szabo G. Dendritic cells in hepatitis C infection: can they (help) win the battle? J Gastroenterol 2011;46:432-447.
32. Chang S, Kodys K, Szabo G. Impaired expression and function of Toll-like receptor 7 in hepatitis C virus infection in human hepatoma cells. Hepatology 2010;51:35-42.
33. Dolganiuc A, Kodys K, Kopasz A, et al. Hepatitis C virus core and nonstructural protein 3 proteins induce pro- and anti-inflammatory cytokines and inhibit dendritic cell differentiation. J Immunol 2003;170:5615-5624.
34. Li K, Li NL, Wei D, et al. Activation of chemokine and inflammatory cytokine response in HCV-infected hepatocytes depends on TLR3 sensing of HCV dsRNA intermediates. Hepatology 2011;55:666-675.